| Market Cap | ₹13,427Cr |
| ROE | 17.73% |
| P/E Ratio(TTM) | 41.51 |
| EPS(TTM) | 30.92 |
| P/B Ratio | 7.35 |
| Dividend Yield | 0.68% |
| Industry P/E | 32.40 |
| Book Value | 174.68 |
| Debt to Equity | 0.00 |
| Face Value | 1 |
| Managing Director | Ankur Jindal |
| Founded | 1984 |
| NSE Symbol | CONCORDBIO |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 40.96 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.05 | ||
| Wockhardt | NA (0.00%) | -2304.35 | ||
| Natco Pharma | NA (0.00%) | 9.87 |